Guest editorial: Breast cancer, Part 1: Issues in diagnosis

Issue: BCMJ, vol. 60 , No. 1 , January February 2018 , Pages 18-19 Editorials

Despite the progress made with new treatments and reduced mortality rates, breast cancer still remains by far the most common malignancy affecting Canadian women.


Dr Rona Cheifetz Dr Elaine McKevitt

Despite the progress made with new treatments and reduced mortality rates, breast cancer still remains by far the most common malignancy affecting Canadian women. An estimated 25 700 new cases were identified in Canada in 2016, and 3500 of these were in British Columbia.[1] Breast cancer remains big news. Articles on breast cancer are common in the popular press, and attention is heightened every time a celebrity faces this diagnosis. Pink ribbons can be found on just about any product, with portions of purchases directed toward breast cancer–related organizations.

While this is the most common cancer in women, and certainly the one that receives that most media attention, many women either significantly overestimate or significantly underestimate their personal breast cancer risk.[2] Either can affect a woman’s decision to pursue screening and seek medical attention for breast concerns and can also increase her anxiety regarding new breast symptoms. Although many breast complaints will not be the result of a malignancy, thorough assessment is still required to exclude malignancy.

Primary care providers are faced with what can be the daunting task of helping patients navigate the process of investigating imaging abnormalities. Multiple appointments for further imaging and biopsy can be required, and patients can become increasingly anxious as they await the results of these tests.

This first in a two-part theme issue dedicated to breast cancer focuses on issues in diagnosis. In the first article, Dr Colin Mar and colleagues provide an overview of the Screening Mammography Program of BC and describe current breast cancer screening policies in the province. The authors include information on the benefits, limitations, and downsides of screening, and encourage primary care providers to discuss these with women at average risk for breast cancer to facilitate informed decision making.

In the second article, Dr Amie Padilla-Thornton and colleagues review the approaches to investigating breast health concerns in symptomatic patients and imaging abnormalities identified in asymptomatic patients. The authors stress the importance of assessment and describe some of the challenges primary care providers and surgeons in different centres may face in organizing investigations.

In the third article, Dr Christine Wilson and colleagues review the Provincial Breast Health Strategy, a plan to facilitate coordinated care in the diagnostic workup for breast abnormalities. The authors discuss the current state of diagnostic services in the province and demonstrate the efficacy of a coordinated system in terms of both timely investigation and cost savings.

In the final article, Dr Katherine Blood and colleagues report on 18 years of data from the High-Risk Clinic of BC Cancer’s Hereditary Cancer Program. The authors describe the uptake rates for risk-reducing surgery and the incidence of new cancers developing in patients under surveillance, including how they were detected. The authors also report on the late age of referral for the majority of women served by the clinic and the need to identify and refer patients with hereditary risk.

In the second part of this theme issue we will focus on breast cancer treatment. Topics covered will include surgical management, radiotherapy, neoadjuvant chemotherapy, and survivorship care. With both parts of this theme issue we hope to help clinicians address some of the challenges of breast cancer care.

—Rona Cheifetz, MD, MEd, FRCSC, FACS
Surgical Oncologist and Medical Lead, High-Risk Clinic, Hereditary Cancer Program, BC Cancer
Associate Professor, Department of Surgery, UBC
Head, Continuing Medical Education, Department of Surgery, UBC

—Elaine McKevitt, MD, MEd, FRCSC, FACS
Surgeon, Mount Saint Joseph Hospital
Chair, Continuing Medical Education and Knowledge Transfer, Surgical Oncology Network, BC Cancer
Chair, Breast Tumor Group, Surgical Oncology Network, BC Cancer
Associate Clinical Professor, Department of Surgery, UBC

hidden


This article has been peer reviewed.


References

1.    Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian cancer statistics 2016. Toronto, ON: Canadian Cancer Society; 2016. Accessed 15 March 2017. www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Can...
2.    de Jonge ET, Vlasselaer J, Van de Putte G, et al. The construct of breast cancer risk perception: Need for a better risk communication. Facts Views Vis Obgyn 2009;1:122-129.

Rona E. Cheifetz, MD, MEd, FRCSC, FACS, Elaine McKevitt, MD, MEd, FRCSC, FACS. Guest editorial: Breast cancer, Part 1: Issues in diagnosis. BCMJ, Vol. 60, No. 1, January, February, 2018, Page(s) 18-19 - Editorials.



Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.